301156 美农生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)5.5636.4237.9779.49424.423
总资产报酬率 ROA (%)5.1996.0877.3077.41216.102
投入资产回报率 ROIC (%)5.5486.4137.8988.41619.665

边际利润分析
销售毛利率 (%)30.66628.81629.93129.03529.574
营业利润率 (%)11.65211.12813.22412.11014.499
息税前利润/营业总收入 (%)11.47610.35812.97010.80715.019
净利润/营业总收入 (%)10.48810.12012.49910.86112.917

收益指标分析
经营活动净收益/利润总额(%)90.92794.34882.535104.27988.650
价值变动净收益/利润总额(%)4.4143.0515.839-1.2304.080
营业外收支净额/利润总额(%)0.6902.2945.004-0.4190.406

偿债能力分析
流动比率 (X)7.18011.38414.7845.9592.180
速动比率 (X)5.8779.80212.7345.3431.671
资产负债率 (%)7.3275.7484.73511.85538.804
带息债务/全部投入资本 (%)0.120-0.3020.0041.51727.961
股东权益/带息债务 (%)82,692.449-33,123.0412,243,683.7556,478.289256.495
股东权益/负债合计 (%)1,264.8271,639.8752,011.918743.514157.703
利息保障倍数 (X)-44.595-10.049-13.639-8.63032.598

营运能力分析
应收账款周转天数 (天)70.31666.97168.22573.18255.438
存货周转天数 (天)69.35974.93872.04970.15660.826